Academic
Keywords
Malignant Melanoma

MM,Malignant Melanoma,malignant melanomas,malignancies melanomas,Malign melanoma

Malignant Melanoma - MM
Publications: 10,319| Citation Count: 91,254
Stemming Variations: malignant melanomas, malignancies melanomas, Malign melanoma
Cumulative Annual
    • Malignant melanoma is a tumor known for its uncontrollable growth and aggressive metastatic behavior. The mean survival time for patients with a metastatic melanoma is estimated to be less than 6 months, tumor cells being refractory to the conventional chemotherapy. A better understanding of the mechanisms regulating melanoma growth and progression might help increase the number of therapeutic options for this pathology...

    ROBERTA M. MORETTIet al. Locally Expressed LHRH Receptors Mediate the Oncostatic and Antimetast...

    • Malignant melanoma (MM) is the most aggressive neoplasm among skin cancers and its incidence is increasing dramatically worldwide. The rise in incidence can be partially related to better screening programs and earlier detections of thin lesions...

    Olivier Gheysenset al. Malignant Melanoma: Localisation and Characterization Using Fluorodeox...

    • Malignant melanoma is a common and frequently lethal disease. Current therapeutic interventions have little effect on survival, emphasizing the need for a better understanding of the genetic, epigenetic, and phenotypic changes in melanoma formation and progression...

    Viswanathan Muthusamyet al. Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma

    • Malignant melanoma is an aggressive and chemoresistant form of skin cancer characterized by rapid metastasis and poor patient prognosis. The development of innovative therapies with improved efficacy is critical to treatment of this disease...

    Alison M. Karstet al. Role of p53 Up-regulated Modulator of Apoptosis and Phosphorylated Akt...

    • Malignant melanoma is an aggressive disease which affects both skin and mucosal surfaces. Primary malignant melanoma of the female lower genital tract, including vulva and vagina, is a rare entity. This disease accounts for only approximately 5–10% of all vulvar malignancies [1]. Primary vaginal melanoma is an even less common variant. Due to the scarcity of malignant melanoma at these sites, there is little evidence-based literature to guide clinicians in the appropriate management of patients...

    Catriona Hardieet al. Primary Malignant Melanoma of the Vulva and Vagina

Sort by: